Shu‐Min Song
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shu‐Min Song has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Hu-Nan Sun
Stem Cell and Regenerative Biology Laboratory, College of Life Science & Biotechnology, Heilongjiang Bayi Agricultural University, Daqing 163319, China
1 shared publication Jie Shi
Daqing Branch of the Heilongjiang Academy of Sciences Daqing China
1 shared publicationLian‐Hui Wei
Daqing Branch of the Heilongjiang Academy of Sciences Daqing China
1 shared publicationQing‐Li Yang
Daqing Branch of the Heilongjiang Academy of Sciences Daqing China
1 shared publicationXing‐Rong Sun
Daqing Branch of the Heilongjiang Academy of Agricultural Sciences Daqing China
1 shared publicationXue‐Song Ma
Daqing Branch of the Heilongjiang Academy of Sciences Daqing China
1 shared publication
Latest Publications
- Open Access
- 9 February 2021
- Published by Wiley in Food Science & Nutrition
- Vol. 9 (4) , 1833-1841
Anticancer property of Hemp Bioactive Peptides in Hep3B liver cancer cells through Akt/GSK3β/β‐catenin signaling pathway
Foodborne protein hydrolysates exhibit biological activity that may be therapeutic in a number of human disease settings. Hemp peptides (HP) generated by controlled hydrolysis of hemp proteins have a number of health benefits and are of pharmaceutical value. In the present study, we produce small molecular weight HP from hemp seed and investigate its anticancer properties in Hep3B human liver cancer cells. We demonstrate that HP treatment increased apoptosis, reduced cell viability, and reduced cell migration in Hep3B human liver cancer cells without affecting the normal liver cell line L02. We correlate these phenotypes with increased cellular ROS levels, upregulation of cleaved caspase 3 and Bad, and downregulation of antiapoptotic Bcl‐2. HP treatment led to increased Akt and GSK‐3β phosphorylation, with subsequent downregulation of β‐catenin, suggesting β‐catenin signaling modulation as a critical mechanism by which HP exhibits anticancer properties. Our findings suggest HP are of potential therapeutic interest for liver cancer treatment.
- 9 February 2021
- Published by Wiley in Food Science & Nutrition
- Vol. 9 (4) , 1833-1841
Open AccessAnticancer property of Hemp Bioactive Peptides in Hep3B liver cancer cells through Akt/GSK3β/β‐catenin signaling pathway
Foodborne protein hydrolysates exhibit biological activity that may be therapeutic in a number of human disease settings. Hemp peptides (HP) generated by controlled hydrolysis of hemp proteins have a number of health benefits and are of pharmaceutical value. In the present study, we produce small molecular weight HP from hemp seed and investigate its anticancer properties in Hep3B human liver cancer cells. We demonstrate that HP treatment increased apoptosis, reduced cell viability, and reduced cell migration in Hep3B human liver cancer cells without affecting the normal liver cell line L02. We correlate these phenotypes with increased cellular ROS levels, upregulation of cleaved caspase 3 and Bad, and downregulation of antiapoptotic Bcl‐2. HP treatment led to increased Akt and GSK‐3β phosphorylation, with subsequent downregulation of β‐catenin, suggesting β‐catenin signaling modulation as a critical mechanism by which HP exhibits anticancer properties. Our findings suggest HP are of potential therapeutic interest for liver cancer treatment.